Article
Massively parallel interrogation of human functional variants modulating cancer immunosurveillance.
Signal transduction and targeted therapy - 19 Mar 2025
Liu Ying, Liu Yongshuo, Niu Xuran, Chen Ang, Li Yizhou, Yu Ying, Mo Binrui, Liu Zhiheng, Xu Tao, Cheng Jie, Wu Zeguang, Wei Wensheng
Abstract excerpt
Anti-PD-1/PD-L1 immune checkpoint blockade (ICB) therapy has revolutionized clinical cancer treatment, while abnormal PD-L1 or HLA-I expression in patients can significantly impact the therapeutic efficacy. Somatic mutations in cancer cells that modulate these critical regulators are closely associated with tumor progression and ICB response. However, a systematic interpretation of cancer immune-related mutations...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
